Issue 27, 2016

Design, synthesis and evaluation of benzenesulfonamide-substituted 1,5-diarylpyrazoles containing phenylacetohydrazide derivatives as COX-1/COX-2 agents against solid tumors

Abstract

Novel benzenesulfonamide-substituted 1,5-diarylpyrazoles containing phenylacetohydrazide derivatives have been designed, synthesized and evaluated for their biological activities as selective COX-2 inhibitors with anticancer potential. In vitro the bioassay results revealed that some of them displayed potent inhibitory activity in the enzymatic and cellular assays. Among them, compound 48 showed the most powerful and potent selective inhibitory activity (IC50 = 82.21 μM for COX-1 and IC50 = 0.37 μM for COX-2), comparable to the control positive compound Celecoxib (40.29 μM, 0.15 μM). Antiproliferative assay results indicated that compound 48 possess potent antiproliferative activity against A549 cells in vitro with an IC50 value of 0.78 μM. We then performed a PI staining assay and cell apoptosis analysis for compound 48 and found that it effectively causes A549 cell apoptosis. A docking simulation was further performed to position compound 48 into the COX-2 active site to determine the probable binding model. The 3D-QSAR models were built for reasonable design of selective COX-2 inhibitors in the future.

Graphical abstract: Design, synthesis and evaluation of benzenesulfonamide-substituted 1,5-diarylpyrazoles containing phenylacetohydrazide derivatives as COX-1/COX-2 agents against solid tumors

Supplementary files

Article information

Article type
Paper
Submitted
25 Jan 2016
Accepted
08 Feb 2016
First published
09 Feb 2016

RSC Adv., 2016,6, 22917-22935

Design, synthesis and evaluation of benzenesulfonamide-substituted 1,5-diarylpyrazoles containing phenylacetohydrazide derivatives as COX-1/COX-2 agents against solid tumors

X. Lu, Z. Wang, T. Wei, X. Yan, P. Wang and H. Zhu, RSC Adv., 2016, 6, 22917 DOI: 10.1039/C6RA02168A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements